Juan Aguilar-Segura
Santiago, RM 8380453, Chile
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
Aminochrome-Induced Disruption of Autophagosome-Lysosome Fusion: Implications for Protein Aggregation in Parkinson's Disease.
Journal: Antioxidants (Basel, Switzerland)
Published: January 30, 2026
Natural Compounds That Activate the KEAP1/Nrf2 Signaling Pathway as Potential New Drugs in the Treatment of Idiopathic Parkinson's Disease.
Journal: Antioxidants (Basel, Switzerland)
Published: August 05, 2024
Targets to Search for New Pharmacological Treatment in Idiopathic Parkinson's Disease According to the Single-Neuron Degeneration Model.
Journal: Biomolecules
Published: March 15, 2024
On the Role of Iron in Idiopathic Parkinson's Disease.
Journal: Biomedicines
Published: September 27, 2023
Single-neuron neurodegeneration as a degenerative model for Parkinson's disease.
Journal: Neural regeneration research
Published: September 18, 2023
Why are neuromelanin-containing dopaminergic neurons lost in idiopathic Parkinson's disease?
Journal: Cellular and molecular life sciences : CMLS
Published: April 10, 2023
A Preclinical Model for Parkinson's Disease Based on Transcriptional Gene Activation via KEAP1/NRF2 to Develop New Antioxidant Therapies.
Journal: Antioxidants (Basel, Switzerland)
Published: February 16, 2023
Protective Effects of Flavonoid Rutin Against Aminochrome Neurotoxicity.
Journal: Neurotoxicity research
Published: August 30, 2022
Astrocytes protect dopaminergic neurons against aminochrome neurotoxicity.
Journal: Neural regeneration research
Published: February 10, 2022
Neuroprotection against Aminochrome Neurotoxicity: Glutathione Transferase M2-2 and DT-Diaphorase.
Journal: Antioxidants (Basel, Switzerland)
Published: December 29, 2021
Last Updated: 09/26/2026